Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir Regimens for COVID-19
NCT04460443Phase 3Unknown
- Sponsor
- Tanta University
- Start
- Aug 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sofosbuvir in coronavirus disease 2019 (COVID-19), sponsored by Tanta University. Status: unknown.
02
Drugs
sofosbuvir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04460443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04460443.